{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:28:16Z","timestamp":1763728096280,"version":"3.44.0"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jviromet.2021.114375","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T02:08:05Z","timestamp":1637719685000},"page":"114375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Insights into the evolutionary and prophylactic analysis of SARS-CoV-2: A review"],"prefix":"10.1016","volume":"300","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8438-706X","authenticated-orcid":false,"given":"Fatima","family":"Akram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikram ul","family":"Haq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amna","family":"Aqeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeeshan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima Iftikhar","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javaria","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rukhma","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jviromet.2021.114375_bib0005","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cell.2020.04.020","article-title":"Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza","volume":"181","author":"Abbott","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jviromet.2021.114375_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2021.02.007","article-title":"Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines","author":"Abdel-Moneim","year":"2021","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2021.114375_bib0015","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jviromet.2021.114375_bib0020","first-page":"536","article-title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses \u2013 a statement of the Coronavirus Study Group","volume":"5","author":"Alexander","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.jviromet.2021.114375_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101615","article-title":"Remdesivir as a possible therapeutic option for the COVID-19","author":"Al-Tawfiq","year":"2020","journal-title":"Travel Med. Infect. Dis."},{"issue":"2","key":"10.1016\/j.jviromet.2021.114375_bib0030","article-title":"Expanded umbilical cord mesenchymal stem cells (UC-MSCs) as a therapeutic strategy in managing critically ill COVID-19 patients: the case for compassionate use","volume":"23","author":"Atlur","year":"2020","journal-title":"Pain Phys."},{"key":"10.1016\/j.jviromet.2021.114375_bib0035","doi-asserted-by":"crossref","DOI":"10.2196\/20735","article-title":"The novel coronavirus enigma: phylogeny and analyses of coevolving mutations among the SARS-CoV-2 viruses circulating in India","volume":"1","author":"Banerjee","year":"2020","journal-title":"JMIR Bioinform Biotech"},{"key":"10.1016\/j.jviromet.2021.114375_bib0040","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1073\/pnas.0805270106","article-title":"Cryo-electron tomography of mouse hepatitis virus: insights into the structure of the coronavirion","volume":"106","author":"Barcena","year":"2009","journal-title":"Proc. Nat. Acad. Sci. USA."},{"key":"10.1016\/j.jviromet.2021.114375_bib0045","doi-asserted-by":"crossref","first-page":"17699","DOI":"10.1038\/s41598-020-74715-4","article-title":"Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2","volume":"10","author":"Basu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jviromet.2021.114375_bib0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4161\/mabs.2.1.10788","article-title":"Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology","volume":"2","author":"Berry","year":"2010","journal-title":"MAbs"},{"issue":"8","key":"10.1016\/j.jviromet.2021.114375_bib0055","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1021\/acsinfecdis.1c00017","article-title":"Screening a library of FDA-Approved and bioactive compounds for antiviral activity against SARS-CoV-2","volume":"7","author":"Biering","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jviromet.2021.114375_bib0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41541-020-00243-x","article-title":"Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses","volume":"5","author":"Bos","year":"2020","journal-title":"Npj Vaccines"},{"issue":"1-2","key":"10.1016\/j.jviromet.2021.114375_bib0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-2999(00)00612-9","article-title":"L-163,491 is a partial angiotensin AT (1) receptor agonist in the hindquarters vascular bed of the cat","volume":"404","author":"Bracken","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jviromet.2021.114375_bib0070","first-page":"1","article-title":"Coronavirus genome structure and replication","volume":"287","author":"Brian","year":"2005","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.jviromet.2021.114375_bib0075","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1128\/JVI.79.3.1635-1644.2005","article-title":"Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus","volume":"79","author":"Brink","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2021.114375_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro","author":"Caly","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jviromet.2021.114375_bib0085","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/1743-422X-7-299","article-title":"Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients","volume":"7","author":"Cao","year":"2010","journal-title":"J. Virol."},{"year":"2020","series-title":"Features, Evaluation and Treatment Coronavirus (COVID-19). 1st Ed","author":"Cascella","key":"10.1016\/j.jviromet.2021.114375_bib0090"},{"key":"10.1016\/j.jviromet.2021.114375_bib0095","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person to person transmission: a study of family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"year":"2020","series-title":"Genotyping Coronavirus SARS-CoV-2: Methods and Implications","author":"Changchuan","key":"10.1016\/j.jviromet.2021.114375_bib0100"},{"key":"10.1016\/j.jviromet.2021.114375_bib0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.micinf.2020.01.004","article-title":"Pathogenicity and transmissibility of 2019-nCoV-a quick overview and comparison with other emerging viruses","volume":"22","author":"Chen","year":"2020","journal-title":"Microb. Infect."},{"key":"10.1016\/j.jviromet.2021.114375_bib0110","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s12250-020-00327-x","article-title":"Human monoclonal antibodies: on the menu of targeted therapeutics against COVID-19","volume":"35","author":"Chen","year":"2020","journal-title":"Virol. Sin."},{"key":"10.1016\/j.jviromet.2021.114375_bib0115","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/infdis\/jiaa278","article-title":"Extended ORF8 gene region is valuable in the epidemiological investigation of severe acute respiratory syndrome-similar coronavirus","volume":"222","author":"Chen","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2021.114375_bib0120","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.1038\/s41467-020-19819-1","article-title":"Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform","volume":"11","author":"Chiuppesi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jviromet.2021.114375_bib0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5802\/crbiol.16","article-title":"Biochemical and statistical lessons from the evolution of the SARS-CoV-2 virus: paths for novel antiviral warfare","volume":"343","author":"Cluzel","year":"2020","journal-title":"C. R. Biol."},{"issue":"13","key":"10.1016\/j.jviromet.2021.114375_bib0130","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jama.2021.3199","article-title":"SARS-CoV-2 vaccines","volume":"325","author":"Creech","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jviromet.2021.114375_bib0135","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10096-020-04088-z","article-title":"Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review","volume":"40","author":"Dao","year":"2021","journal-title":"Eur. J. Clin. Microbial. Infectious Dis.: Off. Publ. Eur. Soc. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2021.114375_bib0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2018.03.003","article-title":"Favipiravir as a potential countermeasure against neglected and emerging RNA viruses","volume":"153","author":"Delang","year":"2018","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jviromet.2021.114375_bib0145","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5582\/ddt.2020.01012","article-title":"Discovering drugs to treat coronavirus disease 2019(COVID-19)","volume":"14","author":"Dong","year":"2020","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.jviromet.2021.114375_bib0150","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV-a target for vaccine and therapeutic development","volume":"7","author":"Du","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"issue":"18","key":"10.1016\/j.jviromet.2021.114375_bib0155","doi-asserted-by":"crossref","first-page":"e152702","DOI":"10.1172\/JCI152702","article-title":"Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City","volume":"131","author":"Duerr","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jviromet.2021.114375_bib0160","article-title":"A new paper about a Gilead drug to combat coronavirus has some analyst skittish about success","author":"Ed","year":"2020","journal-title":"Pharmalot"},{"key":"10.1016\/j.jviromet.2021.114375_bib0165","doi-asserted-by":"crossref","first-page":"110203","DOI":"10.1016\/j.mehy.2020.110203","article-title":"A new approach for COVID-19 treatment by micro-RNA","volume":"143","author":"El-Nabi","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jviromet.2021.114375_bib0170","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/bs.aivir.2016.08.003","article-title":"Molecular basis of coronavirus virulence and vaccine development","volume":"96","author":"Enjuanes","year":"2016","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.jviromet.2021.114375_bib0175","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41586-020-2739-1","article-title":"The coding capacity of SARS-CoV-2","volume":"589","author":"Finkel","year":"2021","journal-title":"Nature"},{"year":"2020","series-title":"Working paper on SARS-CoV-2 spike mutations arising in Danish mink, their spread to humans and neutralization data","author":"Lassauni\u00e8re","key":"10.1016\/j.jviromet.2021.114375_bib0180"},{"key":"10.1016\/j.jviromet.2021.114375_bib0185","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41467-020-20251-8","article-title":"Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity","volume":"12","author":"Fougeroux","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jviromet.2021.114375_bib0190","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad-spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"issue":"2","key":"10.1016\/j.jviromet.2021.114375_bib0195","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1128\/JVI.01248-09","article-title":"Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63","volume":"84","author":"Glowacka","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2021.114375_bib0200","article-title":"The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.jviromet.2021.114375_bib0205","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.chom.2021.02.003","article-title":"Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies","volume":"29","author":"Greaney","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.jviromet.2021.114375_bib0210","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.chom.2020.11.007","article-title":"Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition","volume":"29","author":"Greaney","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.jviromet.2021.114375_bib0215","first-page":"11","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil. Med. Res."},{"issue":"28","key":"10.1016\/j.jviromet.2021.114375_bib0220","first-page":"2100563","article-title":"Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021","volume":"26","author":"Harder","year":"2021","journal-title":"Euro surveillance: bulletin Europeen sur les maladies transmissibles=European communicable disease bulletin"},{"key":"10.1016\/j.jviromet.2021.114375_bib0225","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jviromet.2021.114375_bib0230","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41467-021-20900-6","article-title":"A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication","volume":"12","author":"Hattori","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jviromet.2021.114375_bib0235","article-title":"The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells","author":"Hoffmann","year":"2020","journal-title":"bioRxiv"},{"issue":"10","key":"10.1016\/j.jviromet.2021.114375_bib0240","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jviromet.2021.114375_bib0245","doi-asserted-by":"crossref","DOI":"10.1038\/s41565-020-0674-9","article-title":"Insights from nanomedicine into chloroquine efficacy against COVID-19","author":"Hu","year":"2020","journal-title":"Nat. Nano."},{"key":"10.1016\/j.jviromet.2021.114375_bib0250","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41467-021-21037-2","article-title":"A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jviromet.2021.114375_bib0255","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-021-00839-1","article-title":"Biological activity-based modeling identifies antiviral leads against SARS-CoV-2","author":"Huang","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jviromet.2021.114375_bib0260","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2021.114375_bib0265","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/s41598-021-81462-7","article-title":"Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies","volume":"11","author":"Jena","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jviromet.2021.114375_bib0270","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.jviromet.2021.114375_bib0275","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.cell.2020.04.011","article-title":"The architecture of SARS-CoV-2 transcriptome","volume":"181","author":"Kim","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.jviromet.2021.114375_bib0280","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jviromet.2021.114375_bib0285","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3390\/pathogens9050324","article-title":"Emergence of drift variants that may affect COVID-19 vaccine development and antibody treatment","volume":"9","author":"Koyama","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.jviromet.2021.114375_bib0290","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1126\/science.367.6485.1412","article-title":"Race to find COVID-19 treatments accelerates","volume":"367","author":"Kupferschmidt","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jviromet.2021.114375_bib0295","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis."},{"key":"10.1016\/j.jviromet.2021.114375_bib0300","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1473-3099(09)70069-6","article-title":"Incubation periods of acute respiratory viral infections: a systematic review","volume":"9","author":"Lessler","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jviromet.2021.114375_bib0305","first-page":"1","article-title":"Coronavirus infections and immune responses","volume":"1","author":"Li","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jviromet.2021.114375_bib0310","first-page":"1","article-title":"Coronavirus infections and immune responses","volume":"1","author":"Li","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jviromet.2021.114375_bib0315","article-title":"Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells","author":"Liang","year":"2020","journal-title":"ChinaXiv"},{"key":"10.1016\/j.jviromet.2021.114375_bib0320","article-title":"Distinct genetic spectrums and evolution patterns of SARS-CoV-2","author":"Liu","year":"2020","journal-title":"medRxiv (Health Informatics)."},{"key":"10.1016\/j.jviromet.2021.114375_bib0325","article-title":"Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: a computational biology approach. Infection, genetics and evolution","volume":"84","author":"Lokman","year":"2020","journal-title":"J. Mol. Epidemiol. Evolutionary Genet. Infectious Dis."},{"key":"10.1016\/j.jviromet.2021.114375_bib0330","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jviromet.2021.114375_bib0335","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1111\/1462-2920.15487","article-title":"SARS-CoV-2 biology and variants: anticipation of viral evolution and what needs to be done","volume":"23","author":"Luo","year":"2021","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.jviromet.2021.114375_bib0340","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/jmv.20187","article-title":"Phylogenetic analysis of the full-length SARS-CoV sequences: evidence for phylogenetic discordance in three genomic regions","volume":"74","author":"Magiorkinis","year":"2004","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jviromet.2021.114375_bib0345","doi-asserted-by":"crossref","first-page":"e13013","DOI":"10.1111\/bpa.13013","article-title":"SARS-CoV-2 and the brain: a review of the current knowledge on neuropathology in COVID-19","author":"Maiese","year":"2021","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.jviromet.2021.114375_bib0350","first-page":"68","article-title":"Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments","volume":"40","author":"Malik","year":"2020","journal-title":"Vet. Res. Forum"},{"issue":"7\u20138","key":"10.1016\/j.jviromet.2021.114375_bib0355","first-page":"370","article-title":"Acute respiratory distress revealing antisynthetase syndrome","volume":"73","author":"Maloir","year":"2018","journal-title":"Rev Med Lieg."},{"issue":"4","key":"10.1016\/j.jviromet.2021.114375_bib0360","first-page":"22597","article-title":"COVID-19 immunotherapy: novel humanized 47D11 monoclonal antibody","volume":"29","author":"Marghani","year":"2020","journal-title":"Biomed. J. Sci. Tech. Res."},{"key":"10.1016\/j.jviromet.2021.114375_bib0365","article-title":"PRAK-03202: a triple antigen VLP vaccine candidate against SARS CoV-2","author":"Mazumder","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.jviromet.2021.114375_bib0370","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12985-020-01402-1","article-title":"Characterization of accessory genes in coronavirus genomes","volume":"17","author":"Michel","year":"2020","journal-title":"Virol. J."},{"key":"10.1016\/j.jviromet.2021.114375_bib0375","first-page":"1","article-title":"A Narrative Review of the Clinical Practicalities of Bamlanivimab and Etesevimab Antibody Therapies for SARS-CoV-2","author":"Nathan","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.jviromet.2021.114375_bib0380","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-021-01378-7","article-title":"COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence","author":"Naveca","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.jviromet.2021.114375_bib0385","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1038\/s41467-020-18764-3","article-title":"SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate","volume":"11","author":"Olagnier","year":"2020","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.jviromet.2021.114375_bib0390","doi-asserted-by":"crossref","first-page":"655","DOI":"10.7326\/M20-6976","article-title":"The Proportion of SARS-CoV-2 Infections That Are Asymptomatic: A Systematic Review","volume":"174","author":"Oran","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jviromet.2021.114375_bib0395","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153.x","article-title":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS","volume":"39","author":"Oudit","year":"2009","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.jviromet.2021.114375_bib0400","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41420-020-00358-z","article-title":"RNA 2\u2032-O-methylation modification and its implication in COVID-19 immunity","volume":"6","author":"Paramasivam","year":"2020","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.jviromet.2021.114375_bib0405","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/s41551-020-00603-x","article-title":"Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA","volume":"4","author":"Patchsung","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jviromet.2021.114375_bib0410","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrmicro2147","article-title":"Coronaviruses post-SARS: update on replication and pathogenesis","volume":"7","author":"Perlman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jviromet.2021.114375_bib0415","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.594928","article-title":"Analysis of indian SARS-CoV-2 genomes reveals prevalence of D614G mutation in spike protein predicting an increase in interaction with TMPRSS2 and virus infectivity","volume":"11","author":"Raghav","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jviromet.2021.114375_bib0420","doi-asserted-by":"crossref","DOI":"10.1097\/CM9.0000000000000722","article-title":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study","author":"Ren","year":"2020","journal-title":"Chin. Med. J. (Engl)"},{"key":"10.1016\/j.jviromet.2021.114375_bib0425","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJMoa1604330","article-title":"A randomized, controlled trial of ZMapp for Ebola Virus infection","volume":"375","author":"Richard","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jviromet.2021.114375_bib0430","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","author":"Richardson","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jviromet.2021.114375_bib0435","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)00241-5","article-title":"Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial","volume":"397","author":"Richmond","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jviromet.2021.114375_bib0440","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1086\/651022","article-title":"Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus","volume":"201","author":"Rockx","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"34","key":"10.1016\/j.jviromet.2021.114375_bib0445","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109229118","article-title":"Asymptomatic SARS-CoV-2 infection: a systematic review and meta-analysis","volume":"118","author":"Sah","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.jviromet.2021.114375_bib0450","doi-asserted-by":"crossref","first-page":"e06035","DOI":"10.1016\/j.heliyon.2021.e06035","article-title":"Temporal increase in D614G mutation of SARS-CoV-2 in the Middle East and North Africa","volume":"7","author":"Sallam","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.jviromet.2021.114375_bib0455","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: an old drug against today\u2019s disease","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.jviromet.2021.114375_bib0460","first-page":"10","article-title":"Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)","volume":"38","author":"Shanmugaraj","year":"2020","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.jviromet.2021.114375_bib0465","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad - spectrum antiviral GS -5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jviromet.2021.114375_bib0470","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1002\/jcp.27155","article-title":"Modulation of the immune response by Middle East respiratory syndrome coronavirus","volume":"234","author":"Shokri","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jviromet.2021.114375_bib0475","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1021\/acs.jmedchem.6b01594","article-title":"Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the treatment of ebola and emerging viruses","volume":"60","author":"Siegel","year":"2017","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.jviromet.2021.114375_bib0480","doi-asserted-by":"crossref","first-page":"e13105","DOI":"10.15252\/emmm.202013105","article-title":"A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2","volume":"13","author":"Simonis","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jviromet.2021.114375_bib0485","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3389\/fmicb.2019.00569","article-title":"Recent aspects on the pathogenesis mechanism, animal models and novel therapeutic interventions for middle-East respiratory syndrome coronavirus infections","volume":"10","author":"Skariyachan","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jviromet.2021.114375_bib0490","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/s41467-020-16505-0","article-title":"Immunogenicity of a DNA vaccine candidate for COVID-19","volume":"11","author":"Smith","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.jviromet.2021.114375_bib0495","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00431-020-03766-6","article-title":"Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach","volume":"180","author":"Sperotto","year":"2021","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.jviromet.2021.114375_bib0500","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trend Microbiol."},{"key":"10.1016\/j.jviromet.2021.114375_bib0505","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.bbrc.2006.10.102","article-title":"Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide","volume":"351","author":"Thimmulappa","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jviromet.2021.114375_bib0510","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.cell.2021.01.037","article-title":"Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity","volume":"184","author":"Thomson","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jviromet.2021.114375_bib0515","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41467-020-20653-8","article-title":"SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice","volume":"12","author":"Tian","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.jviromet.2021.114375_bib0520","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1261\/rna.078121.120","article-title":"The viral protein NSP1 acts as a ribosome gatekeeper for shutting down host translation and fostering SARS-CoV-2 translation","volume":"27","author":"Tidu","year":"2020","journal-title":"RNA"},{"key":"10.1016\/j.jviromet.2021.114375_bib0525","doi-asserted-by":"crossref","first-page":"104762","DOI":"10.1016\/j.antiviral.2020.104762","article-title":"Of chloroquine and COVID-19","volume":"177","author":"Touret","year":"2020","journal-title":"Antiviral Res."},{"issue":"7","key":"10.1016\/j.jviromet.2021.114375_bib0530","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.3390\/ijms21072657","article-title":"A review of SARS-CoV-2 and the ongoing clinical trials","volume":"21","author":"Tu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jviromet.2021.114375_bib0535","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/s41467-021-21240-1","article-title":"Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia","volume":"12","author":"Wacharapluesadee","year":"2021","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.jviromet.2021.114375_bib0540","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2021.114375_bib0545","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1038\/s41467-020-16256-y","article-title":"A human monoclonal antibody blocking SARS-CoV-2 infection","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jviromet.2021.114375_bib0550","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.jviromet.2021.114375_bib0555","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.3390\/v2081803","article-title":"Coronavirus genomics and bioinformatics analysis","volume":"2","author":"Woo","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.jviromet.2021.114375_bib0560","unstructured":"World health organization (WHO). Situation reports. Accessed 29 March 2020. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports\/."},{"year":"2020","series-title":"Novel Coronavirus (2019-nCoV) Situation Report-7","author":"World Health Organization (WHO)","key":"10.1016\/j.jviromet.2021.114375_bib0565"},{"key":"10.1016\/j.jviromet.2021.114375_bib0570","article-title":"Compensation of ACE2 function for possible clinical management","author":"Wu","year":"2020","journal-title":"Virol. Sin."},{"key":"10.1016\/j.jviromet.2021.114375_bib0575","article-title":"Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein","volume":"2020","author":"Xia","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jviromet.2021.114375_bib0580","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","article-title":"Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion","volume":"30","author":"Xia","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.jviromet.2021.114375_bib0585","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virusres.2015.02.025","article-title":"The structure and functions of coronavirus genomic 3\u2019 and 5\u2019 ends","volume":"206","author":"Yang","year":"2015","journal-title":"Virus Res."},{"issue":"10","key":"10.1016\/j.jviromet.2021.114375_bib0590","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.7150\/ijbs.45498","article-title":"Targeting the endocytic pathway and autophagy process as a novel therapeutic strategy in COVID-19","volume":"16","author":"Yang","year":"2020","journal-title":"Int. J. Bio. Sci."},{"key":"10.1016\/j.jviromet.2021.114375_bib0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104760","article-title":"The broad spectrum antiviral ivermectin targets the host nuclear transport importin \u03b1\/\u03b21 heterodimer","volume":"177","author":"Yang","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jviromet.2021.114375_bib0600","doi-asserted-by":"crossref","first-page":"624765","DOI":"10.3389\/fchem.2020.624765","article-title":"Structural insight into the SARS-CoV-2 nucleocapsid protein C-Terminal domain reveals a novel recognition mechanism for viral transcriptional regulatory sequences","volume":"8","author":"Yang","year":"2021","journal-title":"Front. Chem."},{"issue":"9","key":"10.1016\/j.jviromet.2021.114375_bib0605","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/s41564-021-00954-4","article-title":"SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution","volume":"6","author":"Zahradn\u00edk","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.jviromet.2021.114375_bib0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105955","article-title":"The epidemiology, diagnosis and treatment of COVID-19","author":"Zhai","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"8","key":"10.1016\/j.jviromet.2021.114375_bib0615","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.cub.2020.03.063","article-title":"Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak","volume":"30","author":"Zhang","year":"2020","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jviromet.2021.114375_bib0620","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2021.114375_bib0625","article-title":"SARS-CoV-2 spike D614G change enhances replication and transmission","author":"Zhou","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2021.114375_bib0630","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bbrc.2004.04.141","article-title":"Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors","volume":"319","author":"Zhu","year":"2004","journal-title":"Biochem. Biophy. Res. Commun."},{"key":"10.1016\/j.jviromet.2021.114375_bib0635","doi-asserted-by":"crossref","first-page":"12123","DOI":"10.1073\/pnas.0701000104","article-title":"Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies","volume":"104","author":"Zhu","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10249","key":"10.1016\/j.jviromet.2021.114375_bib0640","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0140-6736(20)31605-6","article-title":"Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"396","author":"Zhu","year":"2020","journal-title":"Lancet (London, England)."},{"key":"10.1016\/j.jviromet.2021.114375_bib0645","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in china 2019","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med. In press."},{"key":"10.1016\/j.jviromet.2021.114375_bib0650","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.virol.2006.07.046","article-title":"Coronavirus nucleocapsid protein in an RNA chaperone","volume":"357","author":"Zuniga","year":"2007","journal-title":"Virology"}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093421003141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093421003141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:54:16Z","timestamp":1759056856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093421003141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":130,"alternative-id":["S0166093421003141"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2021.114375","relation":{},"ISSN":["0166-0934"],"issn-type":[{"type":"print","value":"0166-0934"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into the evolutionary and prophylactic analysis of SARS-CoV-2: A review","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2021.114375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114375"}}